{"id":986460,"date":"2023-10-25T10:39:43","date_gmt":"2023-10-25T12:39:43","guid":{"rendered":"https:\/\/teknomers.com\/fr\/flash-analyse-ubs-quitte-morphosys-a-acheter-objectif-45-euros\/"},"modified":"2023-10-25T10:39:46","modified_gmt":"2023-10-25T12:39:46","slug":"flash-analyse-ubs-quitte-morphosys-a-acheter-objectif-45-euros","status":"publish","type":"post","link":"https:\/\/teknomers.com\/fr\/flash-analyse-ubs-quitte-morphosys-a-acheter-objectif-45-euros\/","title":{"rendered":"FLASH ANALYSE : UBS quitte Morphosys \u00e0 ‘Acheter’ – objectif 45 euros"},"content":{"rendered":"


\n<\/p>\n

\n

ZURICH (dpa-AFX) – La grande banque suisse UBS a laiss\u00e9 la notation de MorphoSys \u00e0 “Acheter” avec un objectif de cours de 45 euros, selon des chiffres trimestriels pr\u00e9liminaires. Les ventes am\u00e9ricaines du succ\u00e8s au box-office Monjuvi ont \u00e9t\u00e9 conformes aux attentes, \u00e9crit l’analyste Xian Deng dans une premi\u00e8re r\u00e9action disponible mercredi. Les actions de la soci\u00e9t\u00e9 de biotechnologie pourraient r\u00e9agir de mani\u00e8re neutre \u00e0 l\u00e9g\u00e8rement positive \u00e0 court terme.\/edh\/gl<\/p>\n

Publication de l’\u00e9tude originale : 25 octobre 2023 \/ 09h57 \/ GMT Premi\u00e8re diffusion de l’\u00e9tude originale : 25 octobre 2023 \/ 09h57 \/ GMT<\/p>\n

———————-<\/p>\n

dpa-AFX Broker – les nouvelles des traders de dpa-AFX<\/p>\n

———————-<\/p>\n<\/div>\n

\n

Produits \u00e0 effet de levier s\u00e9lectionn\u00e9s sur MorphoSys<\/h2>\n

Avec les knock-outs, les investisseurs sp\u00e9culatifs peuvent participer de mani\u00e8re disproportionn\u00e9e aux mouvements de prix. S\u00e9lectionnez simplement le levier que vous souhaitez et nous vous montrerons les produits ouverts adapt\u00e9s sur MorphoSys.<\/p>\n

L’effet de levier doit \u00eatre compris entre 2 et 20<\/p>\n

Publicit\u00e9<\/span><\/div>\n


\n
ttn-fr-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

ZURICH (dpa-AFX) – La grande banque suisse UBS a laiss\u00e9 la notation de MorphoSys \u00e0 “Acheter” avec un objectif de cours de 45 euros, selon des chiffres trimestriels pr\u00e9liminaires. Les ventes am\u00e9ricaines du succ\u00e8s au box-office Monjuvi ont \u00e9t\u00e9 conformes aux attentes, \u00e9crit l’analyste Xian Deng dans une premi\u00e8re r\u00e9action disponible mercredi. Les actions de […]<\/p>\n","protected":false},"author":1,"featured_media":953466,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[11910,1342,3334,605,60373,1452,893,20413],"class_list":["post-986460","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-acheter","tag-analyse","tag-euros","tag-flash","tag-morphosys","tag-objectif","tag-quitte","tag-ubs"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/986460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/comments?post=986460"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/986460\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media\/953466"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media?parent=986460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/categories?post=986460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/tags?post=986460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}